Novel NOD2 haplotype strengthens the association between TLR4 Asp299gly and Crohn's disease in an Australian population

Inflammatory Bowel Diseases

Volumn 14, Issue 5, 2008, Pages 585-590

  Hume, Georgia E ^a,b   Fowler, Elizabeth V ^a,c   Doecke, James ^b   Simms, Lisa A ^a,b   Huang, Ning ^a,b   Palmieri, Orazio ^d   Griffiths, Lyn R ^e   Florin, Timothy H J ^c,f   Annese, Vito ^d   Radford Smith, Graham L ^a,g  

^a Royal Brisbane and Womens Hospital Research Foundation   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e GRIFFITH UNIVERSITY   (Australia)

^f MATER HOSPITAL   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Crohn's disease; Inflammatory bowel disease; NOD2; TLR4; Toll like receptor

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; AUSTRALIA; CASE CONTROL STUDY; CASPASE RECRUITMENT DOMAIN PROTEIN 15 GENE; COHORT ANALYSIS; COLON CROHN DISEASE; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION; PRIORITY JOURNAL; TOLL LIKE RECEPTOR 4 GENE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; CROHN DISEASE; DNA; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; INCIDENCE; MALE; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROSPECTIVE STUDIES; QUEENSLAND; TOLL-LIKE RECEPTOR 4;

EID: 44349116710     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20362     Document Type: Article

References (24)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411:599-603.
2. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
3. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide is mediated through NOD2. J Biol Chem. 2003;278:5509-5512.
4. Hisamatsu T, Suzuki M, Reinecker HC, et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 2003;124:993-1000.
5. Abreu MT, Arditi M. Innate immunity and Toll-like receptors: clinical implications of basic science research. J Pediatr. 2004;144:421-429.
6. Franchimont D, Vermiere S, El Housni H, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The Toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitits. Gut. 2004;53:987-992.
7. Cario E, Podolsky DK. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun. 2000;68:7010-7017.
8. Arbour NC, Lorenz E, Schutte BC, et al. TLR4. mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet. 2000;25:187-191.
9. Arnott ID, Nimmo ER. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 2004;5:417-425.
10. Gazouli M, Mantzaris G, Kotsinas A, et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol. 2005;11:681-685.
11. Lakatos PL, Lakatos L, Szalay F, et al. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. World J Gastroenterol. 2005;11:1489-1495.
12. Oostenbrug LE, Drenth JP, de Jong DJ, et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:567-575.
13. Brand S, Staudinger T, Schnitzler F, et al. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis. 2005;11:645-652.
14. Braat H, Stokkers P, Hommes T, et al. Consequence of functional Nod2 and Tlr4 mutation on gene transcription in Crohn's disease patients. J Mol Med. 2005;83:601-609.
15. Ouburg S, Mallant-Hent R, Crusius BA, et al. The Toll-like receptor 4 Asp299Gly polymorphism is associated with colonic localisation of Crohn's disease without a major role for the Saccharomyces cervisiae mannan-LBP-CD 14-TLR4 pathway. Gut. 2005;54:439-440.
16. Hayashi F, Smith KD, Ozinsky A, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410:1099-1103.
17. Tallant T, Deb A, Kar N, et al. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiol. 2004;4:33.
18. Hawn TR, Verbon A, Lettinga KD, et al. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J Exp Med. 2003;198:1563-1572.
19. Lodes MJ, Cong Y, Elson CO, et al. Bacterial flagellin is a dominant antigen in Crohn disease. J Clin Invest. 2004;113:1296-1306.
20. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;Suppl A:5-36.
21. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
22. Erridge C, Stewart J, Poxton IR. Monocytes heterozygous for the Asp299gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med. 2003;197:1787-1791.
23. Bonen DK, Ogura Y, Nicolae DL, et al. Crohn's disease-associated NOD2 variants share a signalling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology. 2003;124:140-146.
24. Tanabe H, Ayabe T, Bainbridge B, et al. Mouse Paneth cell secretory responses to cell surface glycolipids of virulent and attenuated pathogenic bacteria. Infect Immun. 2005;73:2312-2320.